Mark D Ericson

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Molecular Docking

Drug Administration

Top Venues

Journal of medicinal chemistry

ACS pharmacology & translational science

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mark D Ericson, Katie T Freeman, Courtney M Larson, Jacob L Bouchard, Kristen John, Mary M Lunzer, Zoe M Koeperich, Carrie Haskell-Luevano
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)]. ACS pharmacology & translational science 7 (4) (2024)
Mark D Ericson, Katie T Freeman, Courtney M Larson, Jacob L Bouchard, Kristen John, Mary M Lunzer, Zoe M Koeperich, Carrie Haskell-Luevano
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)]. ACS pharmacology & translational science 7 (4) (2024)
Mark D Ericson, Katie T Freeman, Courtney M Larson, Jacob L Bouchard, Kristen John, Mary M Lunzer, Zoe M Koeperich, Carrie Haskell-Luevano
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)]. ACS pharmacology & translational science 7 (4) (2024)
Mark D Ericson, Katie T Freeman, Travis M LaVoi, Haley M Donow, Radleigh G Santos, Marc A Giulianotti, Clemencia Pinilla, Richard A Houghten, Carrie Haskell-Luevano
The Parallel Structure-Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands. International journal of molecular sciences 24 (12) (2023)
Mark D Ericson, Linh T Tran, Sarah S Mathre, Katie T Freeman, Kelsey Holdaway, Kristen John, Mary M Lunzer, Jacob L Bouchard, Carrie Haskell-Luevano
Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH 2 ] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH 2 ]. Journal of medicinal chemistry (2023)
Mark D Ericson, Katie T Freeman, Travis M LaVoi, Haley M Donow, Radleigh G Santos, Marc A Giulianotti, Clemencia Pinilla, Richard A Houghten, Carrie Haskell-Luevano
The Parallel Structure-Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands. International journal of molecular sciences 24 (12) (2023)
Skye R Doering, Katie Freeman, Ginamarie Debevec, Phaedra Geer, Radleigh G Santos, Travis M Lavoi, Marc A Giulianotti, Clemencia Pinilla, Jon R Appel, Richard A Houghten, Mark D Ericson, Carrie Haskell-Luevano
Correction to "Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High Throughput 'Unbiased' Screening Campaign". Journal of medicinal chemistry (2023)
Mark D Ericson, Katie T Freeman, Travis M LaVoi, Haley M Donow, Radleigh G Santos, Marc A Giulianotti, Clemencia Pinilla, Richard A Houghten, Carrie Haskell-Luevano
The Parallel Structure-Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands. International journal of molecular sciences 24 (12) (2023)
Mark D Ericson, Courtney M Larson, Katie T Freeman, Lennart Nicke, Armin Geyer, Carrie Haskell-Luevano
Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist Tetrapeptide. ACS omega 7 (31) (2022)
Skye R Doering, Katie Freeman, Ginamarie Debevec, Phaedra Geer, Radleigh G Santos, Travis M Lavoi, Marc A Giulianotti, Clemencia Pinilla, Jon R Appel, Richard A Houghten, Mark D Ericson, Carrie Haskell-Luevano
Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign. Journal of medicinal chemistry 64 (9) (2021)
Mark D Ericson, Skye R Doering, Courtney M Larson, Katie T Freeman, Travis M LaVoi, Haley M Donow, Radleigh G Santos, Rachel H Cho, Zoe M Koeperich, Marc A Giulianotti, Clemencia Pinilla, Richard A Houghten, Carrie Haskell-Luevano
Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist. Journal of medicinal chemistry 64 (19) (2021)
Katherine N Schlasner, Mark D Ericson, Skye R Doering, Katie T Freeman, Mary Weinrich, Carrie Haskell-Luevano
Structure⁻Activity Relationships of the Tetrapeptide Ac-His-Arg-(pI)DPhe-Tic-NH2 at the Mouse Melanocortin Receptors: Modification at the (pI)DPhe Position Leads to mMC3R Versus mMC4R Selective Ligands. Molecules (Basel, Switzerland) 24 (8) (2019)